Rhythm Biosciences Limited (ASX:RHY)
0.0630
0.00 (0.00%)
Nov 17, 2026, 10:36 AM AEDT
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 22.29 million as of November 16, 2026. It is the 38,378th most valuable company in the world and the 1,007th biggest in Australia. Its market cap has decreased by 19.68% in one year.
Market Cap
22.29M
Enterprise Value
19.10M
Revenue
1.74M
Global Rank
Country Rank
#1,007 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has decreased from 32.74M to 22.29M, a decrease of -31.91%. That is a compound annual growth rate of -4.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 22.29M | -49.35% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 619.90M |
| Healius | 417.54M |
| Monash IVF Group | 292.23M |
| Identifai Genetics | 80.63M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.21M |
| BCAL Diagnostics | 22.12M |
| ImExHS | 17.95M |